InsiderClue
Stocks · Health care · Biological Products, (No Diagnostic Substances)

Kymera Therapeutics, Inc.

KYMR Clue Score27
United States Fiscal year ends December CIK 0001815442
$112.40 +2.84% Close, 9 Oct 2026
Alert on the numbers Alert on insider trades
Price $112.40 +113.00% Close, 9 Oct 2026

Closing prices at the end of each trading day, from 21 Aug 2020. Not a live quote. Adjusted for share splits, so the line has no step at a split; dividends are not added back. P/E and P/FCF are the market value over the last full fiscal year's net income or free cash flow, as public on each day, so they step once a year when the annual report comes out. A hatched band marks a stretch with none: a year of net loss, or of cash burnt.

Revenue and profit

What the business sells, and what is left of it. Point at a year for the detail.
RevenueOperating incomeNet income
Fiscal year 2019Revenue2.9Operating income−42.2Net income−41.2Fiscal year 2020Revenue34.0 +1,060.0%Operating income−46.3Net income−45.6EPS, diluted−3.15Fiscal year 2021Revenue72.8 +114.0%Operating income−100.5Net income−100.2EPS, diluted−2.09Fiscal year 2022Revenue46.8 −35.7%Operating income−161.3Net income−154.8EPS, diluted−2.87Fiscal year 2023Revenue78.6 +67.8%Operating income−165.5Net income−147.0EPS, diluted−2.52Fiscal year 2024Revenue47.1 −40.1%Operating income−261.6Net income−223.9EPS, diluted−2.98Fiscal year 2025Revenue39.2 −16.7%Operating income−349.4Net income−311.4EPS, diluted−3.69
FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue 2.9 34.0 72.8 46.8 78.6 47.1 39.2
Growth +1,060.0% +114.0% −35.7% +67.8% −40.1% −16.7%
Operating income −42.2 −46.3 −100.5 −161.3 −165.5 −261.6 −349.4
Net income −41.2 −45.6 −100.2 −154.8 −147.0 −223.9 −311.4
Growth
EPS, diluted n/a −3.15 −2.09 −2.87 −2.52 −2.98 −3.69

Margins

How much of each dollar of revenue it keeps. Point at a year for the detail.
Operating marginNet margin
Fiscal year 2019Operating margin−1,438.5%Net margin−1,405.8%Free cash flow margin592.1%Fiscal year 2020Operating margin−136.1%Net margin−134.0%Free cash flow margin232.2%Fiscal year 2021Operating margin−138.0%Net margin−137.6%Free cash flow margin−179.2%Fiscal year 2022Operating margin−344.4%Net margin−330.6%Free cash flow margin−333.0%Fiscal year 2023Operating margin−210.6%Net margin−187.0%Free cash flow margin−174.7%Fiscal year 2024Operating margin−555.8%Net margin−475.6%Free cash flow margin−440.5%Fiscal year 2025Operating margin−891.1%Net margin−794.0%Free cash flow margin−597.6%
FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Operating margin −1,438.5% −136.1% −138.0% −344.4% −210.6% −555.8% −891.1%
Net margin −1,405.8% −134.0% −137.6% −330.6% −187.0% −475.6% −794.0%
Free cash flow margin 592.1% 232.2% −179.2% −333.0% −174.7% −440.5% −597.6%

Cash flow

The cash the business makes, what it reinvests, and what it hands back. Point at a year for the detail.
Operating cash flowCapital expenditureFree cash flow
Fiscal year 2019Operating cash flow17.9Capital expenditure−0.5Free cash flow17.4Fiscal year 2020Operating cash flow88.1Capital expenditure−9.1Free cash flow79.0 +354.9%Fiscal year 2021Operating cash flow−128.9Capital expenditure−1.6Free cash flow−130.5 −265.2%Fiscal year 2022Operating cash flow−153.1Capital expenditure−2.8Free cash flow−155.9Fiscal year 2023Operating cash flow−102.8Capital expenditure−34.5Free cash flow−137.3Fiscal year 2024Operating cash flow−194.5Capital expenditure−12.8Free cash flow−207.3Fiscal year 2025Operating cash flow−232.9Capital expenditure−1.4Free cash flow−234.3
FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Operating cash flow 17.9 88.1 −128.9 −153.1 −102.8 −194.5 −232.9
Capital expenditure −0.5 −9.1 −1.6 −2.8 −34.5 −12.8 −1.4
Free cash flow 17.4 79.0 −130.5 −155.9 −137.3 −207.3 −234.3
Growth +354.9% −265.2%

Balance sheet

What it holds against what it owes, at each year end. Point at a year for the detail.
Cash
Fiscal year 2019Cash76.0Shareholders’ equity−74.4Fiscal year 2020Cash31.0Shareholders’ equity283.9Fiscal year 2021Cash48.0Shareholders’ equity459.6Fiscal year 2022Cash68.4Shareholders’ equity490.2Fiscal year 2023Cash110.0Shareholders’ equity395.0Fiscal year 2024Cash120.3Shareholders’ equity835.6Fiscal year 2025Cash357.0Shareholders’ equity1,579.7
FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Cash 76.0 31.0 48.0 68.4 110.0 120.3 357.0
Shareholders’ equity −74.4 283.9 459.6 490.2 395.0 835.6 1,579.7

In millions of USD, except per-share figures and ratios. Fiscal years, as last filed with the SEC.

Financial statements FY2025 · 10-K

Balance sheet

In millions of USD, except per-share figures; shares in millions. Fiscal years ending December, each column as last filed with the SEC.
Click a line to chart it
Fiscal year FY2019 31 Dec 2019 FY2020 31 Dec 2020 FY2021† 31 Dec 2021 FY2022 31 Dec 2022 FY2023 31 Dec 2023 FY2024 31 Dec 2024 FY2025 31 Dec 2025
Assets
76.0 31.0 48.0 68.4 110.0 120.3 357.0
n/a n/a n/a 0.0 15.0 0.0 0.0
3.8 10.8 11.9 13.3 48.1 50.5 43.2
116.7 487.2 605.9 603.1 575.8 978.0 1,742.8
Growth +317.5% +24.4% −0.5% −4.5% +69.9% +78.2%
Liabilities
82.0 203.3 146.3 113.0 180.8 142.4 163.1
Equity
−76.5 −128.8 −229.0 −383.8 −530.8 −754.6 −1,066.0
−74.4 283.9 459.6 490.2 395.0 835.6 1,579.7
Growth +61.9% +6.6% −19.4% +111.6% +89.0%
Per share and net cash
1.9 44.5 51.5 55.0 55.6 64.9 81.3
calc −38.56 6.38 8.92 8.91 7.11 12.88 19.42

† The diluted share count jumps at 2021, so per-share figures either side of that column are not comparable. Usually a split, but the break lands on the restatement boundary rather than on the split date, because every column is that period’s latest filing.

Lines marked calc are worked out here from filed figures; point at one for how.